PlainRecalls
FDA Drug Moderate Class II Terminated

Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.

Reported: March 30, 2016 Initiated: February 5, 2016 #D-0781-2016

Product Description

Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.

Reason for Recall

Defective Delivery System: Some units have actuation counters set to a number other than 60.

Details

Units Affected
148,331 Inhalers
Distribution
US: Nationwide Including Puerto Rico
Location
Wilmington, DE

Frequently Asked Questions

What product was recalled?
Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.. Recalled by AstraZeneca Pharmaceuticals LP. Units affected: 148,331 Inhalers.
Why was this product recalled?
Defective Delivery System: Some units have actuation counters set to a number other than 60.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 30, 2016. Severity: Moderate. Recall number: D-0781-2016.